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Abstract
Introduction: COVID-19 is a respiratory disease caused by infection with the virus, SARSCoV-2. Transmission of the virus can occur in both symptomatic and asymptomatic cases
making controlling the spread challenging. Point prevalence testing in long term care facilitates
has been found to be a useful strategy in detecting cases and managing COVID-19 outbreaks.
The impact of this control strategy on severe outcomes of disease in residents of these facilities
has not been fully characterized.
Methods: Active surveillance of COVID-19 in long term care facilities in Connecticut began in
April 2020, with point prevalence surveys beginning in May 2020. Data was collected for 34
facilities from a statewide surveillance system and confirmed through Connecticut’s Electronic
Disease Surveillance System. Data from April 2020 to December 2020 was analyzed to assess
the association between point prevalence testing and severe outcomes.
Results: Overall, there were 2,244 PCR positive residents in 34 facilities between April 2020
and December 2020. Of this group 18.4 % were hospitalized and 25.9% died. Increasing age and
hospitalization were significantly associated with an increased risk of mortality (p<0.001) while
males had a significantly higher risk of hospitalization (p<0.001). The number of point
prevalence surveys conducted by a facility was not significantly associated with either the case
fatality ratio or hospitalization rate within the facility.
Conclusions: Understanding the benefits of point prevalence surveys in LTCFs is important
when looking at the cost effectiveness of the survey and creating recommendations and policies.
There was no association found between the number of point prevalence studies and severe
disease outcomes of residents. Future studies could further investigate the association between
the reason for testing a resident and severe disease outcomes.
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Introduction
Outbreaks in long term care facilities (LTCF) pose a unique challenge to public health
interventions and infection control. Resident factors and facility characteristics contribute to an
increase in spread of infectious diseases and severe outcomes in infected individuals1. Symptom
screening, testing of residents, linkage to care, isolation and good infection control are all
strategies that can be used to manage outbreaks in these settings2,3. Detection based on
symptoms, however, is not as reliable of a strategy when transmission is occurring through
asymptomatic individuals.

First recognized in December 2019, COVID-19 is a respiratory disease caused by infection with
the virus, SARS-CoV-2. Infection with the virus has been shown to be both symptomatic and
asymptomatic with transmission occurring in both4. Symptomatic cases typically manifesting
with fever, cough, congestion, and fatigue4. Atypical symptoms, such as altered mental status
and gastrointestinal symptoms, are frequently seen in elderly patients5. During the COVID-19
pandemic, approximately 40% of infections in LTCFs have been asymptomatic, indicating the
need to use additional methods to detect and isolate cases5-7. Point prevalence testing has been
found to be a useful strategy in detecting cases and managing COVID-19 outbreaks6,8-10.

Residents of LTCFs are typically elderly with multiple comorbid conditions making them highly
vulnerable to COVID-191,2,11. These facilities have been disproportionately impacted by
COVID-19, accounting for 61.6% of deaths in Connecticut during the first two months of the
pandemic3,6. The first case of COVID-19 in a Connecticut LTCF was reported on March 15,
2020 and statewide surveillance for COVID-19 in long term care facilities was established in

6

Connecticut by April 15, 2020 via the Facility Licensing and Investigations Section (FLIS)
reportable events portal of the Connecticut Department of Public Health (CT DPH). The CT
DPH began to recommend point prevalence testing (PPS) of LTCF residents on May 11, 202012.
In accordance with CDC guidelines, facilities were encouraged to test previously negative
residents weekly until there were no new positives for at least 14 days13. At this time, facilities
with active outbreaks were trained on proper infection control and cohorting of positive
residents.

Previous analyses of these point prevalence surveys (PPS) found a high proportion of
asymptomatic infections6 and a significant association of PPS to decreased incidence rates14.
Studies have found support for decreased mortality rates by increased case detection from
frequent testing15 and better outcomes for residents found through PPS compared to symptomatic
testing16. The impact of serial PPS on severe outcomes has largely gone unevaluated, except for
a few studies conducted on a small sample of nursing homes15,16. This study seeks to build
evidence for the protective nature of serial resident PPS against hospitalization and mortality
among LTCF residents. This information could be beneficial in understanding the utility of
repeated prevalence testing and informative of decisions related to policy and cost-effectiveness.

Methods
Point prevalence testing for SARS-CoV-2 in long term care facilities began in May 2020 with
delivery of specimen collection kits beginning on May 2nd. Kits were distributed with the help of
the Connecticut National Guard and CDC. The testing for the PPS consisted of molecular SARS-
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CoV-2 testing through nasopharyngeal (NP) swabs of all residents who had not tested positive
within 90 days and all staff within a facility. Due to limited resources early in the pandemic,
34/212 LTCFs in Connecticut (16%) were prioritized for testing based on the current number of
cases they had, licensed bed size, and ability to impact the spread within the facility6. These 34
facilities comprised the sample for this analysis.

A statewide surveillance system for COVID-19 in all LTCFs was initiated by CT DPH on April
15, 2020. Staff in each facility were required to answer daily questionnaires regarding facility
level data and input individual level data on all cases in a web-based portal (FLIS) maintained by
DPH. Baseline information on the surveys was obtained from this portal and confirmed by phone
for any PPS conducted from May 2020–December 18th 2020. December 18th, 2020 was chosen
as the end date for this analysis to control for any impact vaccination may have had on
hospitalization and mortality. Individual-level demographic information, hospitalization and
mortality status were also extracted from the portal. The demographic information and test
results reported by the LTCF staff were then confirmed in Connecticut’s Electronic Disease
Surveillance System (CTEDSS). Death information reported by the Office of the Chief Medical
Examiner (OCME) is imported into CTEDSS as well and any deaths reported by the LTCF were
checked against this database.

Cases for analysis were restricted to only residents with a PCR positive test result. Case fatality
ratios (CFRs) for each facility were calculated by summing the number of PCR positive test
results and deaths reported to the line list of each facility. Published counts on DPH weekly
reports did not always match the ones pulled from FLIS due to the exclusion of suspect and
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probable cases from this analysis. The hospitalization rate was calculated for each facility by
dividing the number of positive residents that were hospitalized by the total number of positive
residents. Mortality was described and compared with respect to demographic characteristics and
hospitalization status utilizing ANOVA and chi-square tests. Multivariable logistic regression to
assess the association of age, race, and gender with hospitalization and mortality were conducted.
Hospitalization status was also included in the multivariable logistic regression for mortality. A
correlation analysis was also conducted to examine the relationship between the number of PPS
conducted and the CRF and hospitalization rates at the facilities. Analyses and figures were
performed in RStudio version 1.2.1335 using R version 3.6.1.

Results
Between April 15th and December 18th 2020, there were 2,244 PCR positive residents in the 34
LTCFs. Overall, 18.4% of the PCR positive residents were hospitalized and 25.9% of PCR
positive residents died (Table 1). Age and hospitalization were significantly associated with
mortality status (p<0.001). Of those with available demographic information, 83% were nonHispanic white, 12% were Black or African American, and 3% were Hispanic. The majority of
positive residents in the sample were female (65%) and the average age was 80.8 ± 12.1 years
Within the 34 facilities, a median of 10 point prevalence surveys were conducted (range 3 to 17).

Demographic characteristics associated with hospitalization
The number of hospitalizations per facility ranged from 0 cases to 27 cases with a median of 11
cases. In an unadjusted logistical regression, there was a significant association between Black or
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African American race and hospitalization, with this group having 2.59 (95% CI 1.93, 3.45)
times the odds of being hospitalized compared to whites (Table 2). There was no significant
association seen among the other race/ethnicity groups. A statistically significant increased risk
of hospitalization was also seen among males, with men having 1.78 (95 % CI: 1.43, 2.21) times
the odds of being hospitalized compared to females (Table 2). A statistically significant
association between two age groups and hospitalization was also seen. Those aged 81–90 years
old had 0.73 (95% CI: 0.55, 0.98) times the odds of hospitalization compared to those less than
70 years or younger while those 91 years and older saw 0.30 (95% CI: 0.21, 0.43) times the odds
of hospitalization compared to those 70 years or younger. Individuals aged 71-80 did not see a
significant difference in hospitalization compared to those 70 years or younger. Odds ratios were
adjusted using a multivariable logistic regression model. The full model included age, sex, and
race/ethnicity. When adjusted for these variables, older age, male, and Black or African
American remained statistically associated with hospitalization (Table 3). Of these, being male
and Black or African American were associated with an increased risk of hospitalization
compared to being female or White while being older was associated with a decreased risk.

Demographic characteristics associated with mortality
Age and hospitalization were both significantly associated with mortality (p<0.001, Table1).
Gender and race/ethnicity were not significant. As age groups increased, the odds of dying
increased as well. Those 90 years or older had the highest odds, with this group experiencing
3.83 (95% CI 2.78, 5.36) times the odds of death compared to those 70 years or younger (Table
4). Residents that were hospitalized had 3.5 (95% CI 2.80, 4.38) times the odds of death
compared to those who were not hospitalized (Table 4). Upon adjustment for age, sex,
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race/ethnicity and hospitalization using a multivariable logistic regression model, a statistically
significant association was seen between sex and death. Males had 1.49 (95% CI 1.16, 1.80)
times the odds of death compared to females (p=0.001) (Table 5). Hospitalization and age
remained significantly associated with death upon adjustment (Table 5).

Impact of point prevalence surveys
In order to analyze age in relation to point prevalence surveys, the median age at each of the 34
facilities was calculated. The median of facility median ages was 82 years (range 71 to 90 years).
The median case fatality ratio (CFR) among the 34 facilities was 26.3% (range 5.4 to 45%) and
the median percent of residents hospitalized among cases was 16.8% (range 0.0 to 38.5%). A
slight downward trend was observed between the number of PPS conducted and the rate of
hospitalization (R= -0.17) but this was not significant (p=0.32) (Figure 1). No significant
relationship was observed between CFR and the number of PPS conducted (R=0.052, p=0.77)
(Figure 2). A Poisson regression model showed no significant relationship between the number
of PPS conducted and the percent hospitalized. Additionally, no significant relationship was seen
between the number of PPS conducted and the CFR.

Discussion
This analysis looked at both individual and facility level hospitalization and mortality
information among COVID-19 positive residents in a subset of LTCFs. The median case fatality
ratio (26.3%) was similar to those seen in other studies, however the median rate of
hospitalization (16.8%) among positive residents was lower17. These rates varied largely by
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facility, with some having substantially higher rates. The facility with the highest case fatality
ratio, 45%, had a higher median age of residents compared to other facilities at 90 years. Age
may have been a contributing factor to the increased mortality rate in this facility compared to
others.

Age was not consistently associated with hospitalization and mortality among PCR-positive
residents. Decreasing odds of hospitalization was observed with increasing age while there were
increasing odds of death. This contrasts with what has been seen in the general population with
COVID-19 where the risk of death and hospitalization both increase with age18,19. This
difference in risk levels may be specific to long-term care facility residents. These residents are
often older and suffering from more comorbidities compared to the general population, putting
them at risk for more severe COVID-19 outcomes20. The decision about whether or not to send a
resident out to the hospital may be influenced by other factors in addition to how severe their
illness is21. Residents who are older may already be receiving end of life care or families and
residents may decline hospitalization, leading to decreased rates. A more qualitative analysis
may be beneficial in identifying the driving factors behind this relationship. Mehta et al. also
found this opposing pattern of death and hospitalization rates in their study of US nursing home
residents22.

Looking at other demographic characteristics, males saw significantly higher odds of
hospitalization compared to females. This finding was consistent with previous studies18,19,22.
Males also experienced significantly higher odds of mortality compared to females when
adjusted for age, race, and hospitalization status. These findings may be partially explained by
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immune differences and could provide evidence for the need to further study the differences in
outcomes by sex23. Consistent with other studies, Black or African American residents
experienced higher odds of hospitalization but not death19,22. The hospitalization of a resident
was associated with significantly increased odds of mortality in both adjusted and unadjusted
models. Residents that are transferred to the hospital are more likely to be have severe disease
compared to those who remain in the facility. Studies have also shown transfers to be associated
with a higher rate of complications compared to residents remaining in the facility, which may
also play a role in the increased odds of mortality24.

Point prevalence surveys are one way for facilities to improve infection prevention during
outbreaks of infectious diseases where a high number of infectious cases are unable to be
detected symptomatically. Previous studies have provided evidence that these surveys are have
associated with decreased incidence rates and mortality rates, as well as better outcomes among
residents6,15,16. This analysis did not find any association between point prevalence surveys and
decreased case fatality ratios or hospitalization rates among positive residents. This may be due
to the inability to account for factors such as comorbidities or the change in rates of mortality
and hospitalizations over time. Nursing homes were severely affected early in the pandemic, and
a large number of cases were found in the first point prevalence study. Over time, treatment and
detection of cases was improved as an understanding of the disease developed. This may have
led to improved case fatality ratios and hospitalization rates over time that may have been
averaged out by earlier rates.
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One limitation of this analysis is missing or incomplete data due to inconsistent and delayed
reporting by nursing homes. Additionally, testing of residents was difficult early in the pandemic
due to lack of available resources. This contributed to an underestimation of cases, related
hospitalization, and related deaths as this analysis was restricted to only PCR-positive
individuals. Future analysis could compare the outcomes of suspect and probable cases to those
who were confirmed to further explore the relationship between case detection through testing
and COVID-19 outcomes. The homes selected for analysis were prioritized early on due to high
numbers of unknown cases and were all of average size and quality. Future studies could look at
a random sample to increase variation and investigate the impact of PPS under varying
conditions. Information on the reason for testing of each resident was not available for all
residents, so residents found through symptomatic testing or point prevalence surveys were not
able to be separated. This distinction would be important in further analysis.

As the pandemic continues, it will be important to fully understand the benefits of point
prevalence surveys in LTCFs, particularly when looking at the cost effectiveness of the survey
and creating policies. Current information on the benefit is mixed with some studies finding
improvements in outcomes while this one found no impact. Future studies are warranted to help
guide recommendations on when and for what purpose LTCFs should conduct PPS. These
studies could look more closely at reasons for testing individual residents and include
information on comorbidities.
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Tables and Figures:
Table 1. Description of the Sample, by Mortality Status*
Not deceased
Deceased
Characteristic
(n = 1,663)
(n = 581)
Age (years), mean ± SD
79.4 ± 12.4
84.7 ± 10.4
Sex, n (%)
Female
1106 (66.5)
363 (62.5)
Male
557 (33.5)
218 (37.5)
Race, n (%)
White
1314 (82.3)
480 (83.6)
Black or African American
181 (11.3)
71 (12.4)
Hispanic
59 (3.7)
12 (0.2)
Other
42 (2.6)
11 (1.9)
Hospitalized, n (%)
Yes
214 (12.9)
198 (34.1)
No
1449 (87.1)
383 (65.9)

p†
<0.001
0.088
0.197

<0.001

* Numbers may not sum to totals due to missing data, and column percentages may not sum to
100% due to rounding.
†
P-value for analysis of variance F-test (continuous variable) or χ2 test (categorical variable).
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Table 2. Unadjusted associations between study variables and hospitalization
n (%)
Characteristic
N*
OR (95% CI)
Hospitalized
Race/ethnicity
White
1,794
295 (16.4)
1.00
Black or African American
252
85 (33.7)
2.59 (1.93, 3.45)
Hispanic
71
16 (22.5)
1.48 (0.81, 2.55)
Other
53
12 (22.6)
1.49 (0.74, 2.78)
Age (years)
<70
448
111 (24.8)
1.00
71-80
546
113 (20.7)
0.79 (0.59, 1.07)
81-90
724
141 (19.5)
0.73 (0.55, 0.98)
>90
526
47 (8.93)
0.30 (0.21, 0.43)
Sex
Female
1469
224 (15.2)
1.00
Male
775
188 (24.3)
1.78 (1.43, 2.21)
* Numbers may not sum to total due to missing data.
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Table 3. Multivariable logistic regression model of factors associated with hospitalization
(N=2,244)
Adjusted OR
Characteristic
p
(95% CI)
Race/ethnicity
White
1.00
--Black or African American 2.32 (1.72, 3.11)
<0.001
Hispanic
1.18 (0.64, 2.06)
0.584
Other
1.27 (0.63, 2.41)
0.479
Age
0.98 (0.97, 0.99)
<0.001
Sex
Female
1.00
--Male
1.59 (1.27, 2.00)
<0.001
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Table 4. Unadjusted associations between study variables and mortality
Characteristic
N*
n (%) Deceased
OR (95% CI)
Race/ethnicity
White
1,794
480 (26.8)
1.00
Black or African American
252
71 (28.2)
1.07 (0.796, 1.43)
Hispanic
71
12 (16.9)
0.56 (0.28, 1.01)
Other
53
11 (20.8)
1.72 (0.35, 1.35)
Age (years)
<70
448
58 (12.9)
1.00
71-80
546
120 (22.0)
1.89 (1.35, 2.68)
81-90
724
212 (29.3)
2.78 (2.04, 3.86)
>90
526
191 (36.3)
3.83 (2.78, 5.36)
Sex
Female
1469
363 (24.7)
1.00
Male
775
218 (28.1)
1.19 (0.98, 1.45)
Hospitalized
No
1,832
383 (20.9)
1.00
Yes
412
198 (48.1)
3.5 (2.80, 4.38)
* Numbers may not sum to total due to missing data.
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Table 5. Multivariable logistic regression model of factors associated with mortality (N=2,244)
Adjusted OR
Characteristic
P
(95% CI)
Race/ethnicity
White
1.00
--Black or African American 1.04 (0.75, 1.43)
0.797
Hispanic
0.62 (0.30, 1.15)
0.151
Other
0.77 (0.35, 1.51)
0.452
Age
1.06 (1.05, 1.07)
<0.001
Hospitalized
No
1.00
--Yes
4.59 (3.59, 5.90)
<0.001
Sex
Female
1.00
--Male
1.44 (1.16, 1.80)
0.001
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Figure One: Correlation of Facility Hospitalization Rate to Number of PPS Complete

*Shading represents 95% CI
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Figure 2: Correlation of Facility Case Fatality Ratio to Number of PPS Complete

*Shading represents 95% CI
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